Genetic mutations have been identified in melanoma prone families including mutations in cyclin kinase 2A (CDKN2A) and cyclin kinase 4 (CDK4) genes, both of which encode proteins involved in the retinoblastoma pathway [39,40]. The gene discussed is CDKN2A; the disease is melanoma.